Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Martinez-Outschoorn, Ubaldo E  [Clear All Filters]
2015
Lamb R, Ozsvari B, Lisanti CL, Tanowitz HB, Howell A, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease. Oncotarget. 2015.
Lamb R, Fiorillo M, Chadwick A, Ozsvari B, Reeves KJ, Smith DL, Clarke RB, Howell SJ, Cappello ARita, Martinez-Outschoorn UE, et al. Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy. Oncotarget. 2015.
De Luca A, Fiorillo M, Peiris-Pagès M, Ozsvari B, Smith DL, Sánchez-Alvarez R, Martinez-Outschoorn UE, Cappello ARita, Pezzi V, Lisanti MP, et al. Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells. Oncotarget. 2015.
Lamb R, Bonuccelli G, Ozsvari B, Peiris-Pagès M, Fiorillo M, Smith DL, Bevilacqua G, Mazzanti CMaria, McDonnell LA, Naccarato AGiuseppe, et al. Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling. Oncotarget. 2015.
Lamb R, Harrison H, Smith DL, Townsend PA, Jackson T, Ozsvari B, Martinez-Outschoorn UE, Pestell RG, Howell A, Lisanti MP, et al. Targeting tumor-initiating cells: Eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction. Oncotarget. 2015.